# Coagulation, Bradykinin, Polyphosphates, and Angioedema
**Type:** Topics
**Canonical URL:** https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/
## Facts
| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the molecular mechanisms, pathophysiological consequences, and clinical management of Hereditary Angioedema. It covers topics such as the role of kinin receptors, coagulation factors XII and XI, polyphosphate, C1 inhibitor deficiency, and the use of bradykinin-receptor antagonists in the treatment of angioedema. Additionally, it explores the involvement of tissue kallikreins and the contact activation system in the disease pathology. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t11917 |
| Works | 240 |
## Topic papers all
Showing 15 of 240.
- [Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1](https://scholariq.org/papers/endoglin-a-tgf-binding-protein-of-endothelial-cells-is-the-gene-for-hereditary/)
- [Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis](https://scholariq.org/papers/definition-of-organ-involvement-and-treatment-response-in-immunoglobulin-light/)
- [2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides](https://scholariq.org/papers/2012-revised-international-chapel-hill-consensus-conference-nomenclature-of/)
- [The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria](https://scholariq.org/papers/the-international-eaaci-ga2len-euroguiderm-apaaaci-guideline-for-the-definition/)
- [EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis](https://scholariq.org/papers/eular-era-edta-recommendations-for-the-management-of-anca-associated-vasculitis/)
- [International consensus guidance for management of myasthenia gravis](https://scholariq.org/papers/international-consensus-guidance-for-management-of-myasthenia-gravis/)
- [A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets](https://scholariq.org/papers/a-gene-pex-with-homologies-to-endopeptidases-is-mutated-in-patients-with-x/)
- [Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia](https://scholariq.org/papers/fibroblast-growth-factor-23-in-oncogenic-osteomalacia-and-x-linked/)
- [Histopathologic Classification of ANCA-Associated Glomerulonephritis](https://scholariq.org/papers/histopathologic-classification-of-anca-associated-glomerulonephritis/)
- [Hoe 140 a new potent and long acting bradykinin‐antagonist:in vivostudies](https://scholariq.org/papers/hoe-140-a-new-potent-and-long-acting-bradykinin-antagonist-i-in-vivo-i-studies/)
- [Selective Requirement for Src Kinases during VEGF-Induced Angiogenesis and Vascular Permeability](https://scholariq.org/papers/selective-requirement-for-src-kinases-during-vegf-induced-angiogenesis-and/)
- [APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease](https://scholariq.org/papers/i-apol1-i-risk-variants-race-and-progression-of-chronic-kidney-disease/)
- [International Consensus Guidance for Management of Myasthenia Gravis](https://scholariq.org/papers/international-consensus-guidance-for-management-of-myasthenia-gravis-2/)
- [Inflammation and angiotensin II](https://scholariq.org/papers/inflammation-and-angiotensin-ii/)
- [The diagnosis and management of acute and chronic urticaria: 2014 update](https://scholariq.org/papers/the-diagnosis-and-management-of-acute-and-chronic-urticaria-2014-update/)
## Topic primary papers
Showing 15 of 37.
- [A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets](https://scholariq.org/papers/a-gene-pex-with-homologies-to-endopeptidases-is-mutated-in-patients-with-x/)
- [Hoe 140 a new potent and long acting bradykinin‐antagonist:in vivostudies](https://scholariq.org/papers/hoe-140-a-new-potent-and-long-acting-bradykinin-antagonist-i-in-vivo-i-studies/)
- [2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema](https://scholariq.org/papers/2010-international-consensus-algorithm-for-the-diagnosis-therapy-and-management/)
- [Hoe 140 a new potent and long acting bradykinin‐antagonist:in vitrostudies](https://scholariq.org/papers/hoe-140-a-new-potent-and-long-acting-bradykinin-antagonist-i-in-vitro-i-studies/)
- [Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule](https://scholariq.org/papers/megalin-and-cubilin-synergistic-endocytic-receptors-in-renal-proximal-tubule/)
- [Captopril-induced Changes in Prostaglandin Production](https://scholariq.org/papers/captopril-induced-changes-in-prostaglandin-production/)
- [Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study](https://scholariq.org/papers/safety-of-the-oral-factor-xia-inhibitor-asundexian-compared-with-apixaban-in/)
- [International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency](https://scholariq.org/papers/international-consensus-and-practical-guidelines-on-the-gynecologic-and/)
- [The International/Canadian Hereditary Angioedema Guideline](https://scholariq.org/papers/the-international-canadian-hereditary-angioedema-guideline/)
- [Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema](https://scholariq.org/papers/hereditary-angiodema-a-current-state-of-the-art-review-vii-canadian-hungarian/)
- [Disease expression in women with hereditary angioedema](https://scholariq.org/papers/disease-expression-in-women-with-hereditary-angioedema/)
- [The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial](https://scholariq.org/papers/the-contact-activation-inhibitor-ab023-in-heparin-free-hemodialysis-results-of-a/)
- [Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus](https://scholariq.org/papers/definition-acronyms-nomenclature-and-classification-of-angioedema-dance-aaaai/)
- [Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting](https://scholariq.org/papers/misdiagnosis-trends-in-patients-with-hereditary-angioedema-from-the-real-world/)
- [Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial](https://scholariq.org/papers/contact-activation-inhibitor-and-factor-xi-antibody-ab023-produces-safe-dose/)
---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.